Compare Mutual Funds

Pros
Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons
5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

-

INDMoney rank
8/8
6/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

6 Years 9 Months

13 Years 5 Months

Fund AUM

₹854 Cr

₹8306 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹1000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

1.02%

0.91%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

38

39

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(13.34%)
  2. Apollo Hospitals Enterprise Ltd(7.78%)
  3. Torrent Pharmaceuticals Ltd(5.2%)
  4. J.B. Chemicals & Pharmaceuticals Ltd(4.99%)
  5. Ajanta Pharma Ltd(4.53%)
  1. Sun Pharmaceuticals Industries Ltd(13.08%)
  2. Lupin Ltd(7.99%)
  3. Divi's Laboratories Ltd(6.56%)
  4. Dr Reddy's Laboratories Ltd(5.81%)
  5. Cipla Ltd(5.67%)
No of Sectors

2

1

Top 3 Sectors
  1. Health(99.17%)
  2. Basic Materials(0.83%)

Health

(100%)

Equity %

98.45%

99.7%

Debt %

-

-

P/E

37.59

35.73

P/B

5.63

5.7

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

-1.7%

-2.91%

3-Month Return

0.27%

-1.77%

6-Month Return

0.27%

-1.1%

1-Year Return

4.54%

3.24%

3-Year Return

25.86%

24.53%

5-Year Return

16.16%

16.64%

Sharpe

1.15

1.17

Alpha

0.01

0.22

Beta

0.94

0.9

Standard Deviation

15.79

15.21

Information Ratio

-0.35

-0.47

Description

Aditya Birla Sun Life Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Dhaval Shah

Sailesh Raj Bhan, Kinjal Desai, Lokesh Maru, Divya Sharma

Most Popular Comparisons